195 related articles for article (PubMed ID: 35025009)
1. Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma.
Ren S; Wang J; Xu A; Bao J; Cho WC; Zhu J; Shen J
Cell Oncol (Dordr); 2022 Feb; 45(1):57-67. PubMed ID: 35025009
[TBL] [Abstract][Full Text] [Related]
2. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K
Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404
[No Abstract] [Full Text] [Related]
3. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C.
Du Q; Jiang L; Wang X; Wang M; She F; Chen Y
Cancer Sci; 2014 Oct; 105(10):1261-71. PubMed ID: 25154789
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
Zheng H; Chen C; Luo Y; Yu M; He W; An M; Gao B; Kong Y; Ya Y; Lin Y; Li Y; Xie K; Huang J; Lin T
Clin Transl Med; 2021 Jul; 11(7):e497. PubMed ID: 34323412
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
Li Y; He J; Zhong D; Li J; Liang H
J Int Med Res; 2015 Aug; 43(4):494-505. PubMed ID: 26001393
[TBL] [Abstract][Full Text] [Related]
7. ANGPTL2 promotes VEGF-A synthesis in human lung cancer and facilitates lymphangiogenesis.
Liu PI; Jiang YJ; Chang AC; Huang CL; Fong YC; Guo JH; Liu CL; Wang SW; Liu JF; Chang SL; Tang CH
Aging (Albany NY); 2023 Mar; 15(5):1652-1667. PubMed ID: 36917086
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
9. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells.
Ho JY; Lu HY; Cheng HH; Kuo YC; Lee YA; Cheng CH
Cell Oncol (Dordr); 2021 Dec; 44(6):1325-1338. PubMed ID: 34582005
[TBL] [Abstract][Full Text] [Related]
10. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.
Ma C; Xie J; Luo C; Yin H; Li R; Wang X; Xiong W; Zhang T; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Int J Oncol; 2019 Feb; 54(2):572-584. PubMed ID: 30483757
[TBL] [Abstract][Full Text] [Related]
11. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
[TBL] [Abstract][Full Text] [Related]
12. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
13. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
15. JAM-C promotes lymphangiogenesis and nodal metastasis in non-small cell lung cancer.
Hao S; Yang Y; Liu Y; Yang S; Wang G; Xiao J; Liu H
Tumour Biol; 2014 Jun; 35(6):5675-87. PubMed ID: 24584816
[TBL] [Abstract][Full Text] [Related]
16. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma.
Su C; Chen Z; Luo H; Su Y; Liu W; Cai L; Wang T; Lei Y; Zhong B
J Exp Clin Cancer Res; 2011 Sep; 30(1):85. PubMed ID: 21939555
[TBL] [Abstract][Full Text] [Related]
17. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
Du J; Zhang G; Qiu H; Yu H; Yuan W
Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
19. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
20. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Ngiwsara L; Svasti J; Koizumi K
Vasc Med; 2018 Jun; 23(3):201-211. PubMed ID: 29629844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]